BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20606123)

  • 1. B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemia.
    Siriwardena M; Kleffmann T; Ruygrok P; Cameron VA; Yandle TG; Nicholls MG; Richards AM; Pemberton CJ
    Circulation; 2010 Jul; 122(3):255-64. PubMed ID: 20606123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter by Goetze et al regarding article, "B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemia".
    Goetze JP; Johnsen AH; Rehfeld JF
    Circulation; 2011 Feb; 123(6):e232; author reply e234. PubMed ID: 21321178
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter by Kavsak et al regarding article, "B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemia".
    Kavsak PA; Hill SA; Worster A
    Circulation; 2011 Feb; 123(6):e233; author reply e234. PubMed ID: 21321179
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
    McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
    Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndrome.
    Shen XL; Lin CJ; Han LL; Lin L; Pan L; Pu XD
    Int J Cardiol; 2011 Jun; 149(3):296-8. PubMed ID: 20202711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of cardiovascular damage and dysfunction--an overview.
    Collinson PO; Gaze DC
    Heart Lung Circ; 2007; 16 Suppl 3():S71-82. PubMed ID: 17618829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
    Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
    Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia modified albumin, a marker of acute ischemic events: a pilot study.
    Talwalkar SS; Bon Homme M; Miller JJ; Elin RJ
    Ann Clin Lab Sci; 2008; 38(2):132-7. PubMed ID: 18469358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of cardiovascular damage.
    Collinson PO; Gaze DC
    Med Princ Pract; 2007; 16(4):247-61. PubMed ID: 17541289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of existing and novel cardiac biomarkers for cardioprotection.
    Gaze DC
    Curr Opin Investig Drugs; 2007 Sep; 8(9):711-7. PubMed ID: 17729182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation.
    Bassan R; Potsch A; Maisel A; Tura B; Villacorta H; Nogueira MV; Campos A; Gamarski R; Masetto AC; Moutinho MA
    Eur Heart J; 2005 Feb; 26(3):234-40. PubMed ID: 15618053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. We don't need another hero--is there a role for ischemia biomarkers in patients with chest pain?
    Collinson PO
    Clin Chim Acta; 2009 Jun; 404(2):87-8. PubMed ID: 19379720
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia.
    Omland T
    Scand J Clin Lab Invest Suppl; 2005; 240():18-24. PubMed ID: 16112956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure.
    Lewandrowski K
    Clin Lab Med; 2009 Sep; 29(3):561-71. PubMed ID: 19840688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
    Palazzuoli A; Iovine F; Gallotta M; Nuti R
    Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide.
    Gibler WB; Blomkalns AL; Collins SP
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S47-55. PubMed ID: 14564228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of acute coronary syndrome in emergency room.
    Loria V; Dato I; De Maria GL; Biasucci LM
    Minerva Med; 2008 Oct; 99(5):497-517. PubMed ID: 18971915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could BNP screening of acute chest pain cases lead to safe earlier discharge of patients with non-cardiac causes? A pilot study.
    Brown A; George J; Murphy MJ; Struthers A
    QJM; 2007 Dec; 100(12):755-61. PubMed ID: 18089541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
    Javadzadeh J; Collén AC; Manhem K; Swedberg K
    Lakartidningen; 2008 Feb 27-Mar 4; 105(9):616-9. PubMed ID: 18376704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.